Skip to main content
. 2026 Apr 9;24(8):1172–1205. doi: 10.2174/011570159X462267260120104242

Table 2.

Epigenetic regulatory mechanisms of KMT and KDM isoforms in ischemic stroke.

Target Study Model Pathophysiological Mechanism Regulatory Axis Key Finding References
G9a, SUV39H1 PTS
Induced
Mice
Apoptosis G9a, SUV39H1/BDNF Inhibition of G9a and SUV39H1 post-stroke promotes BDNF transcriptional activation. [34]
EZH2 MCAO/R
Induced
Rats
Angiogenesis EZH2/BDNF EZH2 inhibition promotes BDNF transcriptional activation. [35]
EZH2 MCAO/R
Induced
Rats
Apoptosis EZH2/PI3K/Akt/mTOR EZH2 inhibition reduces ischemia-induced apoptosis. [37]
EZH2 MCAO/R
Induced
Rats
Proteostasis
Disruption
EZH2/Foxc1/Ubqln1 Deacetylation of EZH2 promotes Foxc1 expression, subsequently upregulating Ubqln1 and reducing post-stroke protein damage. [38]
SMYD2 MCAO/R
Induced
Mice
BBB Integrity SMYD2/Sphk/S1PR SMYD2 inhibition ameliorates blood-brain barrier damage after stroke. [39]
SETD1B MCAO/R
Induced
Mice
Ferroptosis SETD1B/Tfrc SETD1B inhibition reduces Tfrc expression and alleviates ferroptosis. [42]
KDM4A MCAO/R
Induced
Rats
Inflammation KDM4A/NF-κB KDM4A inhibition suppresses NF-κB activation and attenuates neuroinflammation. [48]
KDM4A MCAO/R
Induced
Mice
Inflammation KDM4A/MDM2/CTRP3 KDM4A inhibition promotes microglial polarization toward an anti-inflammatory phenotype. [49]
KDM6A MCAO/R
Induced
Mice
Inflammation KDM6A/IRF5 KDM6A inhibition suppresses IRF5 activation and alleviates neuroinflammation. [51]
KDM6B MCAO/R
Induced
Rats
Apoptosis KDM6B/BMP2/Bmf KDM6B inhibition reduces post-stroke apoptosis via Bmf downregulation. [53]
KDM1A MCAO/R
Induced
Mice
Apoptosis KDM1A/SPHK2 KDM1A inhibition reduces stroke-induced apoptosis. [44]
KDM2A MCAO/R
Induced
Rats
Apoptosis KDM2A/β-catenin KDM2A inhibition stabilizes β-catenin protein and suppresses apoptosis. [46]